share_log

HC Wainwright & Co. Maintains Buy on Tango Therapeutics, Raises Price Target to $17

HC Wainwright & Co. Maintains Buy on Tango Therapeutics, Raises Price Target to $17

HC Wainwright & Co.維持對Tango Therapeutics的買入,將目標股價上調至17美元
Moomoo 24/7 ·  03/20 06:56

HC Wainwright & Co. analyst Robert Burns maintains Tango Therapeutics (NASDAQ:TNGX) with a Buy and raises the price target from $16 to $17.

HC Wainwright & Co. 分析師羅伯特·伯恩斯維持Tango Therapeutics(納斯達克股票代碼:TNGX)的買入並將目標股價從16美元上調至17美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論